Customised Services in Preclinical Inflammation

Publicerad 2021-02-04

Redoxis is once again accredited for CIR (French Research Tax Reduction)

Redoxis has been granted approval for the French research tax credit (CIR) for 2021, 2022 and 2023 from the French Ministry of Higher Education and Research. This R&D tax credit makes it possible for eligible French research companies to claim tax relief on costs of R&D services outsourced to Redoxis.